First Tracks Biotherapeutics Stock Forecast

Hold candidate since Jun 22, 2026

The First Tracks Biotherapeutics Inc stock price gained 5.17% on the last trading day (Monday, 22nd Jun 2026), rising from $17.42 to $18.32. During the last trading day the stock fluctuated 7.02% from a day low at $17.23 to a day high of $18.44. The price has risen in 7 of the last 10 days and is up by 10.36% over the past 2 weeks. Volume fell on the last day by -940 thousand shares and in total, 496 thousand shares were bought and sold for approximately $9.09 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $19.84 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -24.81% during the next 3 months and, with a 90% probability hold a price between $8.88 and $14.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TRAX Signals & Forecast

The First Tracks Biotherapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.66 and $17.64. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 19.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for First Tracks Biotherapeutics Inc stock

First Tracks Biotherapeutics Inc finds support from accumulated volume at $17.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.21 between high and low, or 7.02%. For the last week, the stock has had daily average volatility of 9.37%.

Our recommended stop-loss: $17.68 (-3.48%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (TRAX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect First Tracks Biotherapeutics Inc to open at $18.00, and during the day (based on 14 day Average True Range), to move between $17.42 and $19.22, which gives a possible trading interval of +/-$1.81 (+/-10.39%) up or down from last closing price. If First Tracks Biotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 10.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $18.60 (1.53%) than the support at $17.42 (4.91%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is First Tracks Biotherapeutics Inc stock A Buy?

First Tracks Biotherapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.703 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $18.00 ( 1.76%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk